IBRX’s Stock Market Puzzle: Piecing Together 2025’s Performance

CSCO Stock

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -49.79%. However, over the last six months, the performance has been stronger by -24.84%. The price of IBRX decreased -11.58% over the last 30 days. And in the last five days, it has fallen by -5.31%.

ImmunityBio Inc (IBRX) stock is currently valued at $2.4. During the last session, the stock experienced a remarkable rise, reaching $30.0 after opening at $2.36. The stock briefly dropped to $5.0 before ultimately closing at $2.41.

The market performance of ImmunityBio Inc’s stock has been turbulent in recent times.

52-week price history of IBRX Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. ImmunityBio Inc’s current trading price is -67.85% away from its 52-week high, while its distance from the 52-week low is 31.42%. The stock’s price range during this time has been between $1.83 and $7.48. The trading volume for the Healthcare sector company’s shares reached about 2.25 million for the day, which was lower than the average daily volume of 9.65 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

ImmunityBio Inc (IBRX) has experienced a quarterly rise of 14.52% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.19B and boasts a workforce of 680 employees.

ImmunityBio Inc: Analysts’ Ratings Unveiled

As of right now, 3 analysts are rating ImmunityBio Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.72, with a change in price of -0.46. Similarly, ImmunityBio Inc recorded 8,355,489 in trading volume during the last 100 days, posting a change of -16.03%.

IBRX Stock Stochastic Average

Today, ImmunityBio Inc’s raw stochastic average for the past 50 days stands at 5.59%, indicating a decline from the raw stochastic average of the last 20 days, which was 10.26%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 8.34% and 6.16% respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.